Clinical Trial Update: Efficacy of Durvalumab in Non-muscle-invasive Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating durvalumab for non-muscle-invasive bladder cancer is underway; full results are not yet available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: Hellenic GenitoUrinary Cancer Group | Conditions: Bladder Cancer | Phase 2 | Status: UNKNOWN